Top Section
Top Section
Executive is moving to more senior role
India is on track for a record year of IPOs. Global tech giants continue to plough capital into a fast-growing consumer economy that is investing heavily in ensuring it’s a major player — along with the US and China — in an AI-first world
◆ Deal finds demand despite arrest of South Korea's president ◆ High single digit concession left for investors ◆ Leads added spread to calm concerns
More articles
More articles
More articles
-
UBS appoints Asia DCM syndicate heads – BNP’s SEA loan syndicate head to relocate – Morgan Stanley’s ECM co-head dies at 41 – Goldman DCM banker moves to Macquarie – CMS’s Chien moves to buy-side – Citi builds Oz team – Wong leaves HSBC -
General Motors’ joint venture sealed a Rmb10.4bn ($1.62bn) deal in the Chinese securitization market on June 6, marking its biggest outing so far. Bankers on the deal said the auto company wanted to bag the cash before onshore rates come under pressure in the second half of the year.
-
Last week, I had the pleasure of taking a short trip back to the UK for a banker friend’s wedding. The weather was as perfect as a London spring day can be, and I was happy to get away from the usual work grumblings of bankers at the pub.
-
Temasek Holdings returned to the securitization market this week after a two year hiatus to woo investors into private equity funds-backed Astrea IV. Institutional investors are already in the bag. The focus now is on winning over retail accounts — the first time such a deal has been open to the city-state’s public, writes Addison Gong.
-
Hua Medicine has filed for an IPO in Hong Kong under sponsors CLSA and Goldman Sachs, as the promised pipeline of biotechnology issuers begins to materialise following the city’s new listing rules.
-
The age-old debate of loans versus bonds has picked up pace amid turbulence in the debt capital markets, as banks and borrowers in Asia try finding the most suitable funding options, writes Pan Yue.
shared comment list
